SAITO YURIKA 斉藤優梨花

… Alternative Names

斉藤優梨花サイトウユリカ

Less

Researcher Number	70970242
Affiliation (Current)	2025: 山形大学, 医学部, 助教
Affiliation (based on the past Project Information) *help	2023: 山形大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 56010:Neurosurgery-related
Keywords	Principal Investigator MDM2 / p53 / がん

新規ライブセルタンパク間相互作用検出法を活用したグリオーマ細胞p53活性化薬の探索Principal Investigator
- Principal Investigator
  
  斉藤優梨花
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  Yamagata University

All 2023

All Journal Article

[Journal Article] CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma Cells2023
- Author(s)
  Togashi Keita、Suzuki Shuhei、Mitobe Yuta、Nakagawa-Saito Yurika、Sugai Asuka、Takenouchi Senri、Sugimoto Masahiko、Kitanaka Chifumi、Okada Masashi
- Journal Title
  
  Cancers
  
  Volume: 16 Issue: 1 Pages: 118-118
- DOI
  10.3390/cancers16010118
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K09202, KAKENHI-PROJECT-23K06689, KAKENHI-PROJECT-23K08492, KAKENHI-PROJECT-23K09020, KAKENHI-PROJECT-20K07631, KAKENHI-PROJECT-21K16867
[Journal Article] Domatinostat Targets the FOXM1?Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents2023
- Author(s)
  Nakagawa-Saito Yurika、Mitobe Yuta、Suzuki Shuhei、Togashi Keita、Sugai Asuka、Kitanaka Chifumi、Okada Masashi
- Journal Title
  
  International Journal of Molecular Sciences
  
  Volume: 24 Issue: 13 Pages: 10817-10817
- DOI
  10.3390/ijms241310817
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K09202, KAKENHI-PROJECT-23K06689, KAKENHI-PROJECT-23K08492, KAKENHI-PROJECT-23K09020, KAKENHI-PROJECT-20K07631, KAKENHI-PROJECT-21K16867
[Journal Article] Antagonizing MDM2 Overexpression Induced by MDM4 Inhibitor CEP-1347 Effectively Reactivates Wild-Type p53 in Malignant Brain Tumor Cells2023
- Author(s)
  Mitobe Yuta、Suzuki Shuhei、Nakagawa-Saito Yurika、Togashi Keita、Sugai Asuka、Sonoda Yukihiko、Kitanaka Chifumi、Okada Masashi
- Journal Title
  
  Cancers
  
  Volume: 15 Issue: 17 Pages: 4326-4326
- DOI
  10.3390/cancers15174326
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K09202, KAKENHI-PROJECT-22K09250, KAKENHI-PROJECT-23K06689, KAKENHI-PROJECT-23K08492, KAKENHI-PROJECT-23K09020, KAKENHI-PROJECT-20K07631, KAKENHI-PROJECT-21K16867, KAKENHI-PROJECT-21H03040
[Journal Article] The Novel MDM4 Inhibitor CEP-1347 Activates the p53 Pathway and Blocks Malignant Meningioma Growth In Vitro and In Vivo2023
- Author(s)
  Mitobe Yuta、Suzuki Shuhei、Nakagawa-Saito Yurika、Togashi Keita、Sugai Asuka、Sonoda Yukihiko、Kitanaka Chifumi、Okada Masashi
- Journal Title
  
  Biomedicines
  
  Volume: 11 Issue: 7 Pages: 1967-1967
- DOI
  10.3390/biomedicines11071967
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K09202, KAKENHI-PROJECT-22K09250, KAKENHI-PROJECT-23K06689, KAKENHI-PROJECT-23K08492, KAKENHI-PROJECT-20K07631, KAKENHI-PROJECT-21K16867

1. 鈴木修平

# of Collaborated Projects: 0 results

# of Collaborated Products: 4 results

SAITO YURIKA 斉藤優梨花

斉藤優梨花サイトウユリカ

Research Projects

Research Products

Co-Researchers

新規ライブセルタンパク間相互作用検出法を活用したグリオーマ細胞p53活性化薬の探索Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma Cells2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Domatinostat Targets the FOXM1?Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Antagonizing MDM2 Overexpression Induced by MDM4 Inhibitor CEP-1347 Effectively Reactivates Wild-Type p53 in Malignant Brain Tumor Cells2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The Novel MDM4 Inhibitor CEP-1347 Activates the p53 Pathway and Blocks Malignant Meningioma Growth In Vitro and In Vivo2023

Author(s)

Journal Title

DOI

Data Source

SAITO YURIKA 斉藤 優梨花

斉藤 優梨花 サイトウ ユリカ

Research Projects

Research Products

Co-Researchers

新規ライブセルタンパク間相互作用検出法を活用したグリオーマ細胞p53活性化薬の探索Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma Cells2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Domatinostat Targets the FOXM1?Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Antagonizing MDM2 Overexpression Induced by MDM4 Inhibitor CEP-1347 Effectively Reactivates Wild-Type p53 in Malignant Brain Tumor Cells2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The Novel MDM4 Inhibitor CEP-1347 Activates the p53 Pathway and Blocks Malignant Meningioma Growth In Vitro and In Vivo2023

Author(s)

Journal Title

DOI

Data Source

SAITO YURIKA 斉藤優梨花

斉藤優梨花サイトウユリカ